menu search

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survival PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption […] The post CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantati... Read More
Posted: Sep 11 2023, 15:32
Author Name: forextv
Views: 092038

Search within

Pages Search Results: